Improving sleep therapy for lung cancer survivors.
Refining Cognitive Behavioral Therapy for Insomnia in Lung Cancer Survivors: Enhancing Feasibility, Acceptability, and Symptom Management
This study is looking to improve a sleep therapy program for lung cancer survivors who often struggle with sleep problems, by making it more helpful and easier to access, so they can feel better and get a good night's rest.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-11035729 on NIH RePORTER |
What this research studies
This research focuses on enhancing Cognitive Behavioral Therapy for Insomnia (CBT-I) specifically tailored for lung cancer survivors, a group that often faces significant sleep disturbances and related symptoms. The project aims to refine the therapy's content and delivery through input from various stakeholders, ensuring it meets the unique needs of this population. By addressing barriers to accessing care, the research seeks to improve the feasibility and acceptability of CBT-I, ultimately testing its effectiveness in alleviating insomnia and associated symptoms like anxiety and fatigue.
Who could benefit from this research
Good fit: Ideal candidates for this research are lung cancer survivors experiencing insomnia and related symptoms.
Not a fit: Patients who do not have a history of lung cancer or who do not experience insomnia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve sleep quality and overall well-being for lung cancer survivors.
How similar studies have performed: Previous research has shown that Cognitive Behavioral Therapy for Insomnia is effective in various cancer populations, suggesting a strong potential for success in this specific group.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Price, Sarah Newmeyer — Wake Forest University Health Sciences
- Study coordinator: Price, Sarah Newmeyer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.